Polymer-controlled drug delivery devices
Total Trials
39
As Lead Sponsor
32
As Collaborator
7
Total Enrollment
8,704
NCT00074737
Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 30, 2004
Completion: May 31, 2007
NCT00291226
Glycine vs Placebo for the Schizophrenia Prodrome
Phase: Phase 2/3
Role: Collaborator
Start: Mar 31, 2006
Completion: Jul 31, 2009
NCT00636155
EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Start: Feb 29, 2008
Completion: May 31, 2012
NCT01247974
Evaluation Of New Onset Postoperative Atrial Fibrillation
Phase: N/A
Start: Dec 31, 2010
Completion: Dec 31, 2012
NCT00967512
Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course
Start: Jan 31, 2012
Completion: Jan 31, 2012
NCT01569594
CorMatrix ECM for Carotid Repair Following Endarterectomy Registry
Start: Apr 30, 2012
Completion: Dec 31, 2016
NCT02073331
Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix)
Start: Mar 31, 2014
Completion: Dec 31, 2017
NCT02184988
Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines
Start: Aug 31, 2014
Completion: Dec 31, 2015
NCT02243124
A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)
Phase: Phase 1
Start: Sep 30, 2014
NCT02334423
A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001
Phase: Phase 3
Start: Jan 31, 2015
NCT02334436
A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002
NCT02418156
A Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction
Start: May 31, 2015
Completion: Mar 31, 2018
NCT02428608
Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006
Completion: Nov 30, 2016
NCT02418143
A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope
Start: Sep 30, 2015
Completion: Feb 29, 2016
NCT02530970
A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope
Start: Oct 31, 2015
Completion: Apr 30, 2018
NCT03322371
Validation of Frontal EEG to Formal Polysomnography in the ICU
Start: Nov 6, 2017
Completion: Jan 1, 2020
NCT03583957
A Wireless EEG Patch for Continuous Electrographic Monitoring
Start: May 8, 2018
Completion: Apr 30, 2026
NCT03425682
ViBone in Cervical and Lumbar Spine Fusion
Start: May 14, 2018
Completion: Jun 30, 2021
NCT03896347
A Study Evaluating 3-Level OLIF Spine Fusion
Start: Jul 1, 2019
Completion: Feb 13, 2020
NCT04060134
A Retrospective Breast Reconstruction Study
Start: Nov 20, 2019
Completion: Jun 1, 2022
NCT04247828
Adaptive and Individualized AAC
Start: Jan 6, 2020
Completion: Aug 31, 2021
NCT04351269
Retrospective Experience Of CIED Implantation
Start: Apr 22, 2020
NCT04717323
Precision Gait Retraining for Children With Cerebral Palsy
Start: Nov 11, 2020
Completion: Jan 31, 2021
NCT04645173
Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation
Start: Feb 2, 2021
Completion: Dec 31, 2023
NCT04762043
MyoVoice to Restore Natural, Hands-free Communication to Individuals With Vocal Impairments
Start: Feb 12, 2021
Completion: Nov 8, 2023
NCT04846127
CanGaroo® Registry Study
Start: May 25, 2021
Completion: Oct 17, 2024
NCT04299282
CIED Implantation in Low BMI Patients
Start: Jun 30, 2021
Completion: Mar 31, 2022
NCT05129319
Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD
Phase: Early Phase 1
Start: Dec 16, 2021
Completion: Jun 15, 2023
NCT05320393
Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines
Start: Mar 30, 2022
Completion: May 22, 2023
NCT05818930
Assessment of Remote EEG Monitoring (REMI-EEG) in Pediatric Emergency and Adult Critical Care Units
Start: Mar 8, 2023
Completion: Oct 31, 2025
NCT05481931
Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
Start: Mar 15, 2023
Completion: Jan 31, 2026
NCT05807412
Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides
Start: May 1, 2023
Completion: Feb 26, 2024
NCT06245174
A Smartphone Application for Neurology and Telemedicine
Start: May 11, 2023
Completion: Sep 30, 2025
NCT05361941
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities
Start: Aug 31, 2023
Completion: Dec 31, 2025
NCT06027749
Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.
Start: Oct 13, 2023
Completion: Jun 1, 2025
NCT06604832
Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture
Start: Sep 3, 2024
Completion: Sep 16, 2025
NCT06337188
Adaptive and Individualized AAC Phase II
Start: Dec 3, 2024
Completion: Mar 1, 2026
NCT06854081
EluPro Antibiotic-Eluting BioEnvelope Registry
Start: Apr 17, 2025
Completion: Dec 31, 2026
NCT06903975
BoTox Into the Sternocleidomastoid Muscles (SCM)
Phase: Phase 4
Start: May 14, 2025
Completion: Mar 31, 2026
Loading map...